Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 818

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1A
Chunk 818
---
 non-compete undertakings of a former employee to demonstrate that the competitive activities
of the former employee will harm one of a limited number of material interests of the employer which have been recognized by the courts,
such as the secrecy of a company’s confidential commercial information or the protection of its intellectual property. If we cannot
demonstrate that such interests will be harmed, we may be unable to prevent our competitors from benefiting from the expertise of our
former employees or consultants and our ability to remain competitive may be diminished.

General Risk Factors

The increasing use of social media platforms
presents new risks and challenges. 

Social media is increasingly being
used to communicate about our research, development candidates, investigational medicines, and the diseases our development candidates
and investigational medicines are being developed to treat. Social media practices in the biopharmaceutical industry continue to evolve
and regulations relating to such use are not always clear. This evolution creates uncertainty and risk of noncompliance with regulations
applicable to our business, resulting in potential regulatory actions against us. For example, subjects may use social media channels
to comment on their experience in an ongoing blinded clinical trial or to report an alleged adverse event. When such disclosures occur,
there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations or we may not be able to defend
our business or the public’s legitimate interests in the face of the political and market pressures generated by social media due
to restrictions on what we may say about our development candidates and investigational medicines. There is also a risk of inappropriate
disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these
events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face regulatory actions, or
incur other harm to our business.

Unfavorable U.S. or global economic conditions
could adversely affect our business, financial condition, or results of operations.

Our results of operations could
be adversely affected by general conditions in the global economy and financial markets, including global pandemics, recent geopolitical
events, unfavorable changes related to interest rates and rising inflation. The most recent global financial crisis caused extreme volatility
and disruptions in the capital and credit markets. A severe or prolonged economic downturn, such as the most recent global financial crisis,
could result in a variety of risks to our business, including weakened demand for our investigational medicines and our ability to raise
additional capital when needed on favorable terms,